Here, we scrutinized the EPHB6 variation by DNA sequencing, and characterized the functional consequences of EPHB6 mutations in vivo and in vitro with regard to their potential role in NSCLC metastasis. This evidence concerns the gene EPHB6 and non-small cell lung carcinoma.